Clinical Trial Update: Tramadol to Reduce Opioid Withdrawal Symptoms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tramadol for reducing opioid withdrawal symptoms in people with opioid use disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal

Drugs mentioned

• Tramadol (tramadol)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED